Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Works by Nichols, R. Charles
Results: 13
1
2
Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report.
- Published in:
- Radiation Oncology, 2012, v. 7, n. 1, p. 1, doi. 10.1186/1748-717X-7-178
- By:
- Publication type:
- Article
3
Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 4, p. 468, doi. 10.1080/0284186X.2021.2016948
- By:
- Publication type:
- Article
4
Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancer.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 10, p. 1164, doi. 10.1080/0284186X.2020.1759821
- By:
- Publication type:
- Article
5
Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: A well-tolerated combination.
- Published in:
- International Journal of Cancer, 2000, v. 90, n. 5, p. 281, doi. 10.1002/1097-0215(20001020)90:5<281::AID-IJC5>3.0.CO;2-U
- By:
- Publication type:
- Article
6
Local salvage of radiorecurrent prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 11, p. 1001, doi. 10.1002/pros.24551
- By:
- Publication type:
- Article
7
Reduction of prostate intrafraction motion using gas-release rectal balloons.
- Published in:
- Medical Physics, 2012, v. 39, n. 10, p. 5869, doi. 10.1118/1.4749932
- By:
- Publication type:
- Article
8
Proton Radiation Therapy Offers Reduced Normal Lung and Bone Marrow Exposure for Patients Receiving Dose-Escalated Radiation Therapy for Unresectable Stage III Non-Small-Cell Lung Cancer: A Dosimetric Study.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 4, p. 252, doi. 10.1016/j.cllc.2011.03.027
- By:
- Publication type:
- Article
9
Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancer.
- Published in:
- Acta Oncologica, 2017, v. 56, n. 7, p. 963, doi. 10.1080/0284186X.2017.1287946
- By:
- Publication type:
- Article
10
A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.
- Published in:
- Acta Oncologica, 2015, v. 54, n. 6, p. 825, doi. 10.3109/0284186X.2014.953260
- By:
- Publication type:
- Article
11
Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 3, p. 498, doi. 10.3109/0284186X.2012.762997
- By:
- Publication type:
- Article
12
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 3, p. 463, doi. 10.3109/0284186X.2013.764467
- By:
- Publication type:
- Article
13
Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer.
- Published in:
- Cancer Investigation, 2019, v. 37, n. 2, p. 85, doi. 10.1080/07357907.2019.1565766
- By:
- Publication type:
- Article